Neuroleptic malignant syndrome due to risperidone misdiagnosed as status epilepticus

Pediatric Reports

Volumn 3, Issue 3, 2011, Pages 81-83

  Arslankoylu, Ali Ertug ^a   Kutuk, Meryem Ozlem ^a   Okuyaz, Cetin ^a   Toros, Fevziye ^a  

^a MERSIN UNIVERSITY   (Turkey)

Author keywords

Neuroleptic malignant syndrome; Risperidone; Status epilepticusreferences

Indexed keywords

CARBIDOPA; CREATINE KINASE; DIAZEPAM; LEVODOPA; RISPERIDONE;

ARTICLE; ARTIFICIAL VENTILATION; ATTENTION DEFICIT DISORDER; BREATHING RATE; CASE REPORT; CHILD; CONVULSION; DEHYDRATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC ERROR; DIAGNOSTIC REASONING; DIAPHORESIS; DRUG EFFECT; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; FEVER; HUMAN; HYPERTHERMIA; HYPOTENSION; LETHARGY; LEUKOCYTOSIS; MALE; MENTAL DEFICIENCY; MENTAL DISEASE; MUSCLE RIGIDITY; NEUROLEPTIC MALIGNANT SYNDROME; PHYSICAL EXAMINATION; PULSE RATE; RESPIRATORY FAILURE; RESPIRATORY TRACT INTUBATION; SCHOOL CHILD; TACHYCARDIA; TREMOR; VOMITING;

EID: 81055124228     PISSN: None     EISSN: 20367503     Source Type: Journal    
DOI: 10.4081/pr.2011.e19     Document Type: Article

References (9)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Revised fourth edition. Washington, DC: American Psychiatric Press; 2000.
2. Leibold J, Patel V, Hasan RA. Neuroleptic malignant syndrome associated with ziprasidone in an adolescent. Clin Ther 2004;26:1105-8.
3. Steingard R, Khan A, Gonzales A, Herzog D. Neuroleptic malignant syndrome: review of experience with children and adolescents. J Child Adolesc Psychopharmacol 1992;2:183-98.
4. Gertz HJ, Schmidt LG. Low melatonin content of substantia nigra in a case of neuroleptic malignant syndrome. Pharmacopsychiatry 1991;24:93-5.
5. Ballard C, Grace J, Mckeith J, Holmes C. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease. Lancet 1998;351:1032.
6. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am 1993; 77:185-202.
7. Srivastava A, Borkar HA, Chandak S. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia. Psychiatry Clin Neurosci 2009;63:119-21.
8. Chungh DS, Kim BN, Cho SC. Neuroleptic malignant syndrome due to three atypical antipsychotics in a child. J Psychopharmacol 2005;19:422-5.
9. Vurucu S, Congologlu A, Altun D, et al. Neuroleptic malignant syndrome due to risperidone treatment in a child with Joubert syndrome J Natl Med Assoc 2009; 101:273-5.